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A B S T R A C T
The aim of this study was to develop a supercritical carbon dioxide (scCO2) spray process to coat solid protein
particles with a hydrophilic polymer. The final purpose is to manufacture drug particles exhibiting controlled
release behaviour in patients. Lysozyme microparticles (about 20 μm) were suspended in a vessel into which a
dextran sulphate (DS) solution was dispersed by scCO2 via a nozzle. Upon interaction with the droplets, DS was
deposited onto or mixed with suspended lysozyme particles. Particles of about 100 μm were obtained. The zeta-
potential analysis and elemental analysis indicated that the top layer of the particles consisted of both lysozyme
and DS. Some of the produced particulate materials showed retarded lysozyme release when exposed to water or
phosphate buffered saline, holding promise for future production of controlled drug delivery systems for ther-
apeutic proteins.
1. Introduction
Protein therapeutics are successfully applied to treat chronic and
life-threatening diseases owing to their high specificity and potency.
One drawback of these drugs is that they have to be administered
parenterally, i.e., intravenously, subcutaneously or intramuscularly,
and often require frequent injections or continuous infusion due to
rapid clearance from the bloodstream [1]. One way to overcome this is
to encapsulate these drugs in an implantable macroscopic or injectable
microparticulate drug delivery system (DDS) from which they are
slowly released after administration. However, the development of an
effective DDS for proteins remains a challenge, as reflected by the low
number of such products on the market [2–5].
Up to now, polymers such as polylactic acid (PLA) and poly(lactic-
co-glycolic) acid (PLGA) have been used as carriers to encapsulate
proteins [6]. The use of these polymers, however, comes with
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disadvantages such as denaturation of proteins during production be-
cause of contact with the polymers, organic solvents and interfaces, and
the formation of acidic degradation products causing a local drop in pH
during release, leading to protein aggregation and incomplete protein
release [7].
As an alternative to the conventionally used polymers, hydrophilic
polymers could be employed, which are more protein friendly. In the
past decades, the interest for natural or chemically modified poly-
saccharide-based polymers in the development of controlled drug de-
livery systems has increased due to their stability, safety, non-toxicity,
hydrophilicity and biodegradability [8–12]. Charged polymers like
polyelectrolytes are widely applied in food, biotechnology, pharma-
ceutical and cosmetic industry and are used as dispersing agent, pur-
ification reagent, conditioner, etc. [13–15]. In addition to these appli-
cations, polyelectrolytes have been studied as coating material for food
and pharmaceutical purposes [16,22] with a number of advantages
[18]. One of them is that the coating process can be performed in an
aqueous environment under mild conditions without the use of organic
solvents, which helps to preserve the bioactivity of sensitive biomole-
cules like proteins. Proteins can be easily incorporated within poly-
electrolyte materials, because they are natural polyelectrolytes them-
selves, and due to their amphotericity the protein charge can be
changed through a well-chosen shifted pH [19,20]. The complex for-
mation with the polyelectrolyte might however affect the protein
structure and activity [18].
For the purpose of controlled protein release, polyelectrolytes may
be employed to build up multi-layer coatings (LbL (layer by layer)) by
the application of alternating positively-charged and negatively-
charged polyelectrolytes [16]. Compared with conventional en-
capsulation methods like emulsion-solvent extraction/evaporation
[6,21], i) LbL coating does not require harmful organic solvents; ii)
avoids the use of thermal evaporation steps which can damage the
protein; iii) the protein release behaviour can be adjusted by selecting
the proper types of polyelectrolytes, arranging the number of coating
layers and modifying the interactions among the charged polymers
[16,18,22].
It would be even more advantageous if we were able to carry out
protein coating by polyelectrolytes in supercritical carbon dioxide
(scCO2). ScCO2 has been examined as a solvent to process protein
pharmaceuticals because of its mild critical temperature and pressure,
nontoxicity, the absence of solvent/water interfaces and it does not
leave traces in the product [23]. ScCO2 can be applied as a drying
medium for the proteins and for the production of formulated protein-
containing microparticles [24]. In addition, via changes in the kinetics
of CO2 depressurization, the particle morphology can be controlled to
generate materials of variable density and surface roughness [25].
Protein encapsulation for controlled release using scCO2 has been
investigated before [25–32]. In these studies, hydrophobic materials
such as PLA, PLGA and lipids, were usually selected as the coating
materials, and in some cases organic solvents were applied. As far as we
know, there have been no studies on protein coating using polyelec-
trolytes in scCO2 processes.
The selection of polymer-based coating methods for microparticle
encapsulation depends on many factors like the desired final coating
layer thickness and product particle size. Spraying coating involves
bringing core particles in contact with the sprayed polymer-containing
droplets. Conventionally, this coating process provides many ad-
vantages such as uniform coating, coating layer thickness control, and
multilayer coating [33,34]. By combining the aforementioned ad-
vantages of spray coating and scCO2 processes including drying under
mild conditions, a novel approach can be developed for producing
controlled release protein formulations.
This paper reports on an exploratory study aimed at evaluating the
possibility of developing a scCO2 process to coat dry protein-containing
hydrophilic micro-sized core particles with a shell of a single type of
biodegradable and hydrophilic polyelectrolyte. In this study lysozyme
was chosen as a model protein and dextran sulphate (DS) as the coating
material. The obtained dry microparticles were characterised for par-
ticle morphology, residual moisture content, protein release profile,
zeta-potential and surface composition.
2. Experimental
2.1. Materials and preparations of feed solutions
Hen egg white lysozyme (∼70000 U/mg, Sigma-Aldrich, St. Louis,
USA) was dissolved in ultrapure water (purified using a Milli-Q ultra-
pure water system, Millipore™, Molsheim, France) and was used for the
production of lysozyme core microparticles via a scCO2 spray drying
process (see 2.2). DS (dextran sulphate) (Sigma-Aldrich, St. Louis, USA)
solution (10% w/w) was also prepared in ultrapure water for the spray
coating onto lysozyme core particles. For the in vitro study on the
protein release performance, a phosphate buffer was prepared with
phosphate salts (Na2HPO4 and NaH2PO4) and sodium chloride (NaCl)
(Sigma-Aldrich, St. Louis, USA). All liquid formulations were filtered
through a 0.22 μm cellulose filter (Whatman, GE Healthcare, Freiburg,
Germany) before experiments. For all the scCO2 related processes, CO2
(99% purity) was purchased from Linde group (Linde Gas Benelux BV,
The Netherlands).
2.2. Preparation of lysozyme core particles
Prior to the coating experiments, solid spray-dried lysozyme core
microparticles were prepared according to previous methods, with a
uniform spherical morphology with a relatively narrow size distribution
[24]. Briefly described, lysozyme solution (10% w/w) was prepared
with ultrapure water as the solvent. An amount of 20 ml of this solution
was sprayed into a 4-litre scCO2 spray drying vessel via a co-axial
nozzle (inner liquid diameter 0.05 cm and outer scCO2 diameter
0.24 cm) at a solution flow rate of 0.2 ml/min, scCO2 flow rate of 30 kg/
h, a temperature of 37 °C and a pressure of 130 bar.
2.3. Particle suspension & spray coating (PSSC) process
2.3.1. Experimental set-up
Fig. 1 illustrates the scheme of the scCO2 spray coating process. The
scCO2 was supplied by a diaphragm pump (LEWA, Leonberg, Germany)
to a half-litre pressure vessel.
During the process, an amount of solid lysozyme core particles was
placed in the vessel, followed by warming and pressurization with the
CO2. With the help of the agitator (a shaft with both disk turbine and
pitched-blade turbine mounted), the lysozyme powder was suspended
in the vessel. DS solution was fed into the vessel by a high-pressure
piston pump (ISCO, Lincoln, USA). By means of a nozzle-contained T-
mixer in which single-hole nozzles were placed, DS solution and scCO2
were mixed and sprayed into the vessel, which is explained in detail
below. Products from the process were collected at the bottom of the
vessel where paper filters were placed. The paper filter was prepared by
cutting normal printing paper fitting the inner bottom of the vessel. Ten
layers of the paper were fixed at the bottom of the vessel. The paper
filter remained intact after the spray coating process.
In order to conveniently describe the process developed in our
study, it is named particle suspension & spray coating (PSSC) process.
2.3.2. Nozzle configurations
These experiments aimed to investigate the influence of different
nozzle configurations on the dispersion of the DS liquid. Four types of
nozzle arrangements in the T-mixer, named C1, C2, C3 and C4, re-
spectively, as shown in Fig. 2, were tested to evaluate the influence of
the nozzle configuration on the dispersion of polymer droplets. C1, C2
and C3 had configurations that bend the scCO2 flow while C4 had a
configuration of straight flow. First the vessel was filled with CO2. In all
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Fig. 1. Sketch of the PSSC experimental set-up. ScCO2 was pressurized and heated to supercritical state (in this study to 130 bar and 37 ° C), and introduced into the spray & coating vessel
via a nozzle-contained T-mixer, in which the high-speed scCO2 flow atomizes the DS solution (introduced by an ISCO pump) into tiny droplets. A disk turbine and pitched-blade turbine
were placed in the spray & coating vessel to mix the core particles (placed in the vessel before pressurization) and the atomized polymer droplets.
Fig. 2. Scheme of the configurations (C1, C2, C3 and C4) of the nozzle-contained T-mixers applied in the PSSC process. Nozzles (shown as the hole embedded in the blue cylinders) with
different sizes were connected in T-mixers made by cylinder tubes (about 9.5 mm inner diameter). The arrows show the direction of the fluids. The nozzle wall plate thickness was about
1- 2 mm (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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these experiments, a scCO2 flow rate of 300 g/min was applied during
the spraying process. The operating conditions were maintained at a
temperature of 37 ° C and a pressure of 130 bar. Ten ml DS solution
(10% w/w) was introduced into the vessel at a flow rate of 0.2 ml/min.
The agitator rotated at a rate of 500 rpm. The liquid drops were dried as
the result of quick mass transfer between water and scCO2. After the
injection of DS solution, the vessel was flushed for 30 min at 300 g/min
with fresh scCO2 to avoid making products with a high residual
moisture content.
2.3.3. Processing conditions
Several experiments were performed to evaluate the applicability of
the PSSC process for the coating of lysozyme core particles (see
Table 1).
During these experiments, 1 g lysozyme core particles was sus-
pended in scCO2 in the half-litre pressure vessel with an agitation at
500 rpm, which is higher than the minimum required agitation speed
(about 170 rpm) for solid suspension based on an classical equation
pioneered by Zwietering [35]. The vessel was pressurized with scCO2,
and was regulated at a flow rate of 300 g/min at 130 bar and 37 ° C.
Once the pressure was stable, 10 ml DS solution (10% w/w) was ato-
mized into the vessel together with the scCO2 via the T-mixer nozzle.
The overall mass ratio of lysozyme to DS during this process was 1:1.
The feeding rate of DS was varied to learn about the influence of this
parameter on the coating of the core particles. After the injection of DS
solution, the vessel was flushed with scCO2 (300 g/min) for 30 min with
agitation for further contact of particles and sprayed DS droplets, as
well as the removal of the residual water from the vessel. After de-
pressurization, the product was recovered from the filter on the bottom
of the vessel for further analysis.
The samples collected with different operating conditions are
named as Control, S1, S2 and S3, respectively.
2.4. Particle characterisation
2.4.1. Particle size distribution
DS solution was atomized using different nozzle configurations (see
2.3.2) and dried in the vessel. The particle size distribution of the spray
dried DS microparticles was measured by the tri-laser diffraction light
scattering technique using a Microtrac S3500 particle analyser (Mi-
crotrac S3500, Montgomeryville, USA). Microtrac FLEX software (ver-
sion 10.3.14) was used to calculate the particle size distribution. The
device offers two operating modes, i.e., a wet (fluid dispersion) mode
and a dry (air dispersion) mode. In the wet mode, the liquid-particle
shear and implemented sonification help the homogenisation of the
samples; in the dry mode, air flow is used for powder dispersion. In
terms of the measurement size range, the wet mode has a lower de-
tection limit (about 0.02 um) than the dry mode (about 0.2 um). The
wet mode seems to be better for particle size determination. However, a
proper liquid medium is needed to avoid sample dissolution and sample
interaction.
Methanol was used as the liquid medium as it is a non-solvent for
DS. Sonification (2 min at an ultrasound power of 25 W) was used to
improve the homogeneity of the suspension. A refractive index value of
1.59 for particles and 1.33 for methanol was used. A measurement size
range of 0.02–1408 μm was selected. Each sample was measured in
duplicate and the averaged particle size distribution (each measure-
ment itself was the average of triplicated recycling measurements) was
reported.
The size distribution of particles obtained from the PSSC process
was measured by the same device in the dry (air dispersion) mode to
maintain the solid state of the collected particles and to avoid re-dis-
solution (as lysozyme can be dissolved in solvents like methanol) and
unexpected inter-particle interaction. During the measurement, the dry
powder was blown through the beam by means of pressure and sucked
into a vacuum cleaner. During the dry mode measurement, the size
range of 0.2–1408 um was used and each sample was measured once.
2.4.2. Scanning electron microscope and energy dispersive spectroscopy
A scanning electron microscope (SEM), integrated with Energy
Dispersive Spectroscopy (EDS) (JSM-6010LA, JEOL, Tokyo, Japan) was
used to examine the morphology of the microparticles as well as the
elemental composition of the microparticle surface. Conductive double
sided tape was used to fix the particles to the specimen holder before
sputtering them with a thin layer of Au-Pd. All the samples were ana-
lysed in map mode during EDS analysis, where the distribution and
intensity of elements were measured in the scanned area and a sum-
marised elemental composition of the scanned area was reported.
The EDS analysis was performed for lysozyme, DS, Control, S1, S2
and S3 at the accelerating voltages of 10 kV), counting rate higher than
1000 cps and dead time lower than 4%. Elemental carbon (C), nitrogen
(N), oxygen (O) and sulphur (S) were measured as feature elements to
distinguish lysozyme and DS. For the EDS analysis, at least 3 different
particles were chosen for elemental composition analysis. The average
values of the elemental compositions of the measured particles together
with their standard deviations are reported.
The influence of different accelerating voltages on the detected
elemental composition was investigated. S3 was selected for this mea-
surement for its relatively high detected sulfur content (see 3.5). One
particle of S3 was selected; three different positions on the particle were
measured for elemental content in the sequence of 5, 10, 15 and 20 kV.
The average value of the measured elemental compositions of the three
detected positions under each accelerating voltage is reported.
2.4.3. Zeta-potential analysis
Zeta-potential measurements are commonly employed to determine
whether the electrical charge on the surface of a particles is positive or
negative, and is used as a means of monitoring the deposition of surface
layers [36].
A polar liquid medium has to be used for the zeta-potential mea-
surement. Zeta-potential of the product was measured in ethanol (ra-
ther than methanol to avoid the possible dissolution of lysozyme [37]),
in which lysozyme and DS are only sparingly soluble, via electro-
phoretic light scattering (ELS) combined with phase analysis light
scattering (PALS) (Zetasizer Nano ZS, Malvern Instruments, Malvern,
UK). About 0.01 g sample powder was put in a cuvette filled with 1 ml
ethanol, followed by immediate measurement. Refractive indices of
1.36 and 1.59 were used for ethanol and particles, respectively. A
voltage of 5 V was applied during the measurement. Each sample was
measured in triplicate and the mean zeta-potential value, standard
deviation of the triplicated measurement and zeta-deviation, which
reflects the width of the charge distribution obtained in the experiment
[38] and was calculated by Malvern Zetasizer Software v7.11, were
reported.
2.4.4. Moisture content analysis
The moisture content measurements of the samples were conducted
with a Karl-Fischer coulometer (Metrohm 756F, Herisau, Switzerland).
An amount of powder (about 0.01 g) was weighed in a chromatography
vial, which was sealed after loading the powder, followed by the ad-
dition of 1 ml methanol. After half an hour water extraction by me-
thanol, 0.1 ml of the water-methanol mixture was injected into the
Table 1
Operating conditions used for the PSSC process.
Sample DS concentration (w/w) Flow rate (ml/min) Nozzle configuration
Control 0% 1 C4
S1 10% 0.2 C4
S2 10% 0.5 C4
S3 10% 1 C4
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coulometer sample chamber for analysis. The measurement was per-
formed in triplicate and the average value with the standard deviation
was reported as percentage of the sample weight (% w/w).
2.4.5. Protein concentration determination
The lysozyme concentration was determined with the use of a UV
spectrophotometer (Agilent 8453, Agilent Technologies, Santa Clara,
USA). The dissolved lysozyme sample was placed in a cuvette with path
length of 1 cm and absorbance at 280 nm was measured. By using an
extinction coefficient of 2.64 ml mg−1 cm−1 [39], the lysozyme con-
centration in the measured sample was calculated.
2.4.6. Protein load determination
In order to determine the total lysozyme content in the product
particles (containing both lysozyme and DS), about 2 mg of powder was
dissolved in 1 M NaCl solution (at room temperature), where it is as-
sumed that all the protein-polyelectrolyte complexes would dissociate
at this high ionic strength.
2.4.7. Protein release studies
Lysozyme release profiles were achieved with the following proce-
dure: 0.13 g powder was added to a flask, along with 13 ml purified
water, or phosphate buffered saline (PBS) (pH 7.4; 10 mM phosphate
salts (Na2HPO4 and NaH2PO4); 150 mM NaCl). The release experiments
were performed in an incubator-shaker at 37 °C and 200 rpm. At dif-
ferent time points (1 h, 1 day, 2 days and 4 days) 1.5 ml of the dis-
solution medium was transferred into an Eppendorf tube and simulta-
neously 1.5 ml of the corresponding fresh medium was added to the
sample flask. After centrifugation for 15 min at 18000 x G, a UV spec-
trum of the supernatant was recorded.
3. Results
3.1. Configuration of nozzle-contained T-mixer
This section treats the performance of the tested nozzle configura-
tions in the T-mixer with respect to DS droplet dispersion. One of the
tested nozzle configurations was selected for the later PSSC process. DS
solutions were sprayed by using the different nozzle configurations
shown in Fig. 2. It was aimed to disperse DS liquids into droplets with a
size smaller than the core particles, while avoiding the presence of
droplets larger than the core particles (see 4.1.1 for discussions).
The number-based and volume-based size distributions of spray
dried DS particles obtained with different nozzle configurations are
shown in Fig. 3. The volume-based particle size is biased toward larger
particles.
All the applied four nozzle configurations show comparable
number-based particle size distributions with an average particle size of
5 μm. The spray-dried DS particles from C3 have the highest ratio
(about 80%) of particles with a (volume-based) size larger than that of
the core particles (about 90 μm (volume-based)) compared to the rest of
nozzle configurations (C1: about 60%; C2: about 63% and C4: about
71%). During the experiments, a blockage of the outlet nozzle some-
times happened due to the rapid drying of tiny droplets by scCO2 inside
the T-mixer. Thus, it was better to avoid the nozzle positioned in the
outlet of the T-mixer and C3 was not selected for the PSSC process.
Although there is a presence of large particles of about 1000 μm for
C1 and C4, the number of these particles is minimal. To avoid the risk of
outlet nozzle blockage, C1 was not selected for the PSSC process. The
scCO2 transport in C2 involves a bend in the tube, while for C4 the
tubing is more straight, which is preferable with respect to avoiding
hindrance and resistance encountered during scCO2 transport.
Therefore C4 was selected as the configuration for the droplet genera-
tion in the PSSC process.
3.2. Morphology and size distribution of particles obtained via the PSSC
process
SEM was performed to study i) the morphology of the lysozyme core
particles, which were produced via spray drying; ii) particles from the
control experiment; and iii) particles formed after spray coating with
DS in the PSSC process. The results are shown in Fig. 4. The used ly-
sozyme core particles were spherical with an average diameter of about
20 μm. After the PSSC process, with either water (Control) or DS
spraying, only a few original core particles were found back, and most
particles seemed to consist of agglomerates of differently shaped sub-
particles, mostly much larger than the core particles (up to hundreds of
micrometres). Apparently some dissolution and reconstitution of the
lysozyme had taken place.
It appeared that the sample S2 (where DS solution flowrate was
0.5 ml/min) consisted of agglomerates of a larger size than the other
samples. However, these agglomerates consisted of sub-particles with a
size similar to the particles in S1 (DS solution flowrate of 0.2 ml/min)
and S3 (DS solution flowrate of 1 ml/min).
In the sample of S1, there were many 1–2 μm small particles de-
posited onto the surface of large particles, where in S2 and S3 such
small particles were much less abundant. SEM images of S1 at higher
magnification are provided in the supplementary materials
(Supplementary figures and tables, Fig. 2).
Laser diffraction particle size analysis was performed to study the
size of the sample particles relevant to the PSSC process. The results are
shown in Fig. 5. The lysozyme core particles had an average size of
about 20 μm (number-based). After the PSSC process, big particles
(often agglomerates) of about hundreds of micrometre size were pro-
duced. Although the particles in S2 were visible with SEM as clusters of
hundreds of microns, the measured particle size distribution (number-
based) shows no significant increase in particle size compared to S1,
and S3 was much bigger according to the size distribution. Apparently,
the clusters are loose aggregates of smaller particles (sub-particles). The
aggregates become separated during the particle analysis with air dis-
persion. As indicated by the size distribution (see Fig. 5), the Control
and S3 samples apparently contain more large particles (i.e., size >
100 μm) than S1 and S2.
Although with SEM small particles could be observed (similar to the
core particles, around 20 um) these small particles were not detected
(e.g. in Control, S2 and S3) by the laser diffraction particle size dis-
tribution. It may be possible that during laser diffraction analysis the
large particles overshadow the small ones during measurement, or the
amount of small particles is not enough to induce signal intensity over
the detection limit, as recently shown for PLGA microparticles [40].
3.3. Residual moisture content
It has been reported [24] that a residual moisture content below 3%
should be low enough to maintain the chemical and/or conformational
stability of protein products over time. However, the influence of water
on the stability of proteins depends on the protein type and its for-
mulation, thus it cannot be generalized for all situations.
In this study, the residual moisture content is also an indication of
the humidity level in the vessel as a result of the DS spraying flowrate.
The residual moisture content of the samples is shown in Table 2. The
average moisture content of lysozyme core particles produced via scCO2
spray drying was 2.5%, similar to the dried protein formulation
moisture content as reported before [24]. For the Control sample as
well as the products obtained via PSSC process with DS, moisture
contents of about 3–5% were obtained. According to a T-test (per-
formed via the Data Analysis toolbox of Excel 2010), the moisture
contents of the samples S1 and S2 differed insignificantly from that of
the lysozyme core particles. There was a statistically significant dif-
ference between the moisture content of the lysozyme core particles
and S3 (P < 0.05), indicating a higher residual moisture content after
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the particle-droplet interaction at a higher DS flow rate. Moreover, S3
also shows a significant difference from that of the Control sample.
3.4. Zeta-potential
Table 3 shows the zeta-potential of lysozyme, DS, and products from
the PSSC process. As expected, lysozyme displayed a positive mean
zeta-potential, opposite to that of DS. Control samples from the PSSC
process showed a positive mean zeta-potential, consistent with the re-
sults for the pure lysozyme. The DS-lysozyme products from the PSSC
process all showed a negative mean zeta potential and S1 showed a
more negative zeta-potential than S2 and S3.
Broad zeta deviations of the sample particles were observed, espe-
cially for the product of the PSSC process where the zeta deviation was
even higher than the mean zeta-potential.
3.5. EDS analysis
Energy dispersive (X-ray) spectroscopy (EDS) analysis was con-
ducted to evaluate the composition of the product particle top layer (a
few μm depth) in a dry state after the PSSC process. Fig. 6 shows the
elemental composition of lysozyme, DS and the samples obtained from
the PSSC process, including the Control sample and the ones containing
DS. Four elements, that is C, N, O and S, were selected as representative
elements for the identification of materials in the product. In lysozyme,
the S content was minimal with about 2% detected mass percentage
where C and N dominated, as expected. In DS, N was a trace element
where O and S contents were both higher than those in lysozyme,
because of the presence of the hydroxyl groups and sulphate groups.
The detected elemental compositions of lysozyme and DS are compar-
able with references [41,42]. The Control sample shows similar content
of elements as lysozyme. In all the products from the PSSC process
containing DS, the mass content of S and N falls in between that of
lysozyme and DS. At 10 kV accelerating voltage, the EDS analysis can
reach a penetration depth of a few micrometres into the sample [43].
Therefore, according to the EDS analysis, on the top layer of the product
particles from the PSSC process, there was a combination of lysozyme
and DS (as expected from a coating).
The product particles of S3 were (because of the relatively high
sulphur content of S3) selected to be measured under different accel-
erating voltages to study the influence of this factor on the particle
composition. The information is provided in the supplementary mate-
rials (Supplementary figures and tables, Fig. 3). According to the re-
sults, lysozyme was the dominating material of the detected particles
with a mass ratio over 70%, and the calculated compositions of the
detected particles differed slightly as function of accelerating voltage.
3.6. Protein release profile
The in vitro protein release profile of DS-encapsulated lysozyme
particles obtained via PSSC process was examined. The sample S1 and
S2 showed burst release in PBS of about 80–90% at 1 h (the first time
point) without showing the expected controlled release behaviour. The
lysozyme release profiles of S1 and S2 are provided in the supple-
mentary materials (Supplementary figures and tables, Fig. 4). Only the
protein release profile of Control and S3 sample are shown in Fig. 7. The
Fig. 3. Particle size distribution, measured in wet mode by laser diffraction, of spray dried DS which were produced via nozzle configurations C1, C2, C3 and C4 (see Fig. 2 and text for
details). This particle size distribution is the average of duplicated measurements. The particle size distributions of each measurement are supplied in the supplementary materials of this
paper (Supplementary figures and tables, Fig. 1).
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Control sample, protein without DS, showed an immediate lysozyme
release both in water and in PBS, where 100% protein release was al-
ready measured at first time point. In water, where the ionic strength is
low, the release of lysozyme from the S3 particles was limited to about
20% after 4 days, while in PBS, a quick lysozyme burst release of about
70% was detected after 1 h and a cumulative release up to 90% was
reached after 4 days.
Fig. 4. SEM images of core lysozyme parti-
cles to be coated in the PSSC process (see
Fig. 1 and text for details), Control sample
(with water spraying instead of DS spraying)
and products from PSSC process (sample S1,
S2 and S3) with DS spraying. A magnified
image of S1 shows that there are small
particles deposited onto the surface of large
particles. The magnified image of S2 shows
that the big particles are clusters of particles
with a size in the same magnitude order as
that in S1 and S3. SEM images of S1 at
higher magnifications are provided in the
supplementary materials (Supplementary
figures and tables, Fig. 2).
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4. Discussion
4.1. Influence of the spraying conditions on particle coating
4.1.1. Optimal spraying droplet size
A small (DS) droplet size with a homogeneous size distribution of
Fig. 5. Particle size distribution, measured in dry mode by laser diffraction, of lysozyme core particles, Control sample and sample S1, S2 and S3 produced via PSSC process.
Table 2
Residual moisture content of samples of the PSSC process.
Sample Moisture content (%)
Lysozyme core particles 2.5 ± 1.1
Control 3.0 ± 0.7
S1 3.4 ± 1.1
S2 3.1 ± 0.8
S3 4.9 ± 0.5
Table 3







Lysozyme 34.4 7.6 19.2
DS −42.6 2.3 19.7
Control 16.0 5.9 25.5
S1 −20.8 3.5 21.3
S2 −6.4 2.4 30.9
S3 −5.9 1.5 42.6
a Average zeta-potential of triplicate measurements.
b Standard deviation of the mean zeta-potential of triplicate measurements.
c A zeta-potential deviation reported by Malvern Nano-zetasizer, representing the
distribution of zeta-potential contributed from differently charged particles [38].
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dissolved coating material is expected to give optimal coating
[33,44–46]. According to previous literature [47] on the correlation
between spraying droplet size and favourable particle coating, it is
predicted that the size of droplets must be smaller than that of the core
particle (micrometre range) in order to obtain the coating of the core
particles with relatively little agglomeration.
Due to the closed high-pressure system, the droplet size could not be
observed directly. Therefore, an effort was made here to derive the
droplet size indirectly. The size of the dispersed DS droplets was de-
termined based on the size of the spray-dried DS particles. When as-
suming that one droplet creates one primary DS particle by the process
of drying, a mass balance allows calculating the original droplet size.
According to the number based particle size distribution, the ma-
jority of the spray dried DS particles ranged in size from 2 to 15 μm,
with an average size of about 5 μm. DS particles have a density of about
1.96 g/cm3 [48] and the 10% (w/w) DS solution has a measured den-
sity of about 1.05 g/cm3 (via an Anton Paar DMA 5000 density meter
(data not included)). If it is assumed that both the droplets and the
spray-dried particles have a spherical shape, the size of the dispersed DS
droplets can be calculated to be been between 5 and 40 μm.
In order to assess whether the dispersed DS droplets had been al-
ready completely dried before their contact with the core particles, a
simple mass transfer simulation based on Fick’s law using Comsol
Multiphysics software was conducted, using the diffusion coefficients of
water and scCO2 in the corresponding medium that were reported be-
fore [49,50]. The simulation results are displayed in the supplementary
materials (Supplementary figures and tables, Fig. 5). Based on this si-
mulation, theoretically in fresh scCO2, it takes about 0.5 ms to 20 ms for
the sprayed DS droplet to be dried. The spraying scCO2 flow rate is
about 30 m/s at the nozzle tip, and the travel distance for the dispersed
droplets for the contact with suspending particles is about 10 cm, cor-
responding to a residence time of approximately 3 ms. This means that
part of the DS particles may be pre-dried before their contact with the
solid core lysozyme particles.
A small number fraction of the spray dried DS particles has a large
size of hundreds of micrometres, suggesting that the original droplet
size is even bigger. These large droplets should dry slowly in scCO2 and
may be one of the factors leading to possible re-dissolution and mis-
shaping of micro core particles or formation of bridges and agglomer-
ates among them, as reflected by the SEM images of the samples (see
Fig. 4).
The average size of the sprayed DS droplets (number-based) is about
half the average size of the core particles (about 20 μm). This suggests
that the majority of the dispersed droplets are smaller than those of the
core particle, which should be favourable for the coating of core par-
ticles [47].
4.1.2. DS spraying flow rate and residual moisture content
This study aims to produce DS-encapsulated lysozyme particles with
the help of scCO2. In the PSSC process, the scCO2 flow rate was always
300 g/min while the DS solution injection flow rate was varied from
0.2 ml/min to 1 ml/min in the different experiments. In general, at
small volumes of liquid with large volumes of gas using twin-fluid
nozzles, a higher liquid flow rate tends to lead to larger droplet sizes
[51], implying that the droplet size can be controlled by varying the
gas-to-liquid mass ratio (GLR) through the nozzle [52]. From this we
expect to generate larger droplets at higher DS solution flow rates.
Larger droplets may also form by coalescence of the dispersed
droplets before drying and the larger droplets will take longer to dry
due to the limited mass transfer in the water-scCO2 binary system. If the
droplets cannot leave the system through the paper filter at the bottom
of the vessel (something which is not known), this might lead to an
increase of the hold-up of water in the vessel.
These combined phenomena resulted in a higher residual moisture
content of the particles at a DS flow rate of about 1 ml/min
(GLR ≈ 300) (about 5% (w/w) moisture content) compared to that at
flow rate of 0.2 and 0.5 ml/min (GLR = 1500 and 600, respectively;
about 3-3.5% moisture content; see Table 2).
At equal flow rates (1 ml/min), the residual moisture content of the
particles for the Control experiment with only water spraying is lower
(about 3%) than for that of S3 (about 5%). This is probably related to
the approximately 20% higher viscosity, and slightly lower (about 6%)
surface tension of the 10% DS solution (see Supporting figures and
tables, Table 1), giving rise to larger droplets during the atomisation
Fig. 6. Elemental composition of lysozyme, DS and products of PSSC process detected by
EDS at an accelerating voltage of 10 kV.
Fig. 7. Lysozyme release profile from the Control and S3 sample particles in water and
PBS at 37 ° C.
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and to reduced transport rates. Moreover, the amount of water bound to
DS may also contribute to the difference of the residual moisture. Less
than 2 water molecules are bound per sugar ring onto DS [48], re-
presenting an amount of residual water of less than 0.08 g for the 1 g of
sprayed DS. This would theoretically add maximally 4% to the moisture
content of the (complex) protein particles, so this might explain the
higher moisture content of S3 compared to the Control (no DS).
4.2. Composition of produced particles and efficacy of the coating
The present study was meant to learn whether lysozyme core par-
ticles could be coated with DS through the PSSC process. According to
the SEM images, spherical core lysozyme particles (see Fig. 4) ag-
glomerate into larger particles during the PSSC process. Only few ori-
ginal lysozyme particles are still present in the Control sample (with the
addition of just water in the absence of DS), and mainly new, ag-
glomerated particles are visible in which the original spherical shapes
of the lysozyme core particles are hardly present anymore. This might
be explained from a dissolution-growth mechanism. Such a process
probably also takes place in the presence of DS (see Fig. 4, S1, S2 and
S3), in addition to the coating of the core lysozyme by DS.
Whether the protein core particles were indeed coated by DS was
evaluated by both the zeta-potential and the elemental composition on
the top layer of the product microparticles.
Zeta-potentials of the samples from the PSSC process were measured
(in ethanol) and compared with the measured values for lysozyme
(about +34 mV) and DS (about −43 mV). The reverse of the zeta-po-
tential from positive to negative values indicates that there is DS pre-
sent at the particle surface.
For S1, a low DS injection flow rate was used. According to the
discussion in 4.1.1, this low DS flow rate may lead to a pre-drying of DS
before it comes in contact with or coats the lysozyme core particles (see
Supplementary figures and tables, Fig. 2). During the zeta-potential
measurement, those DS particles which were more loosely attached to
the agglomerates, contribute to the broad zeta-deviation and tend to
shift the mean zeta-potential to more a negative value. The samples
from the PSSC process contain particles that differ greatly in size,
morphology and composition (i.e., lysozyme to DS ratio), which will
give rise to different zeta-potential values.
EDS analyses were performed to learn whether the particles from
the PSSC process were partly coated by DS. In this study, S was re-
garded as the representative element of DS. DS has a theoretical S
content of 15% (w/w) compared to 2% for lysozyme, and the measured
values were 30% and 2%, respectively. Theoretically lysozyme contains
20% N with 29% measured. Through calculations based on the S and N
mass contents and the mass ratios of C and O to the representative
elements, a mixture of DS and lysozyme was detected on the top layer
of the S1, S2 and S3 sample particles whereby the detected DS content
of S3 was higher than that of S1 and S2.
Based on the morphology of the product samples, the zeta-potential
and EDS analysis, it can be concluded that mixed particles can be
produced consisting of lysozyme and DS. However, a conclusion on the
homogeneity and completeness of the core particle coating in the PSSC
process cannot be drawn yet.
4.3. Protein release behaviour from the produced particles
Retarded protein release is the final target of the DS coated lyso-
zyme particles obtained via the PSSC process. When suspending the DS-
containing PSSC processed particles (S3) in PBS, after one hour about
70% of the lysozyme was released in the solution. When placed in
water, however, this initial release was much less (about 10%). One
factor causing the burst release of lysozyme is the dissolution of pure
protein particles. The product particles of S3 exhibited about 10% less
initial (i.e. after 1 h) burst release in PBS than those of S1 and S2 (see
Supplementary figures and tables, Fig. 4), where S3 had a higher DS
content than S1 and S2. The protein Control sample without DS dis-
solved completely in one hour.
The much faster release at the higher ionic strength of the PBS,
compared to water was expected [1] and is probably due to a weakened
electrostatic interaction between lysozyme and DS.
After the initial burst release, a slow release stage followed. Since
the Control sample did not have such a slow phase, this slow release
stage has to be related to the DS. It apparently hampers the dissolution
or the diffusion of the protein, by binding to it or by forming a layer
around the protein particle [53–55]. Such a shell type layer would swell
when the particle comes into contact with the water and forms a dif-
fusion barrier.
As for the lysozyme release in S1 and S2, after exposing the particles
in vitro to PBS for about two days, a decrease of free dissolved lysozyme
was detected (see Supplementary figures and tables, Fig. 4). Com-
plexation of released lysozyme with free polyelectrolyte may account
for the detected decrease of the lysozyme concentration [56].
The product particles from the PSSC process formulated with DS
show some slow release behaviour. To prolong the release of lysozyme,
a next step could be to treat the DS formulated particles with a cationic
hydrophilic polymer such as DEAE-dextran (diethylaminoethyl-dextran
hydrochloride). This polymer might form a layer on top of a possible DS
layer of the current product particles and the newly-formed particles
are expected to exhibit slower release profiles. Thicker layers might be
constructed by repeated DS-DEAE-dextran layer deposition.
5. Conclusion
In this study, a scCO2 spray coating process was developed to de-
monstrate the possibility of coating lysozyme core particles by hydro-
philic polyelectrolyte. Core microparticles agglomerated into larger
particles during the process, pointing at the interaction between solid
protein particles and polymer droplets. Zeta-potential and EDS analysis
indicate that DS was deposited onto or mixed with lysozyme in the
agglomerated product particles. In some cases, a reduced lysozyme
release rate was observed for the product particles, compared to the
Control (no DS). This study lays the foundation for the achievement of
layer-by-layer encapsulation of protein particles via scCO2 processes.
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